Literature DB >> 15178407

Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB.

Bysani Chandrasekar1, Federica M Marelli-Berg, Masahide Tone, Sailaja Bysani, Sumanth D Prabhu, David R Murray.   

Abstract

We investigated whether beta-adrenergic receptor (beta-AR) stimulation induces the expression of interleukin (IL)-18, a proinflammatory cytokine, in myocardium and in cardiac-derived endothelial cells (CDEC) via activation of nuclear factor (NF)-kappaB. Our results indicate that isoproterenol (ISO) activates NF-kappaB DNA binding activity, and induces myocardial and systemic elaboration of IL-18 via beta2-AR signaling. Furthermore, in CDEC, ISO increased basal and inducible promoter activities, increased IL-18 gene transcription and mRNA stability, and induced IL-18 expression via beta2-AR agonism. Signaling required GiPI3K, PI3K, Akt, IKK, and NF-kappaB. In conclusion, our results indicate for the first time that isoproterenol induces myocardial and systemic elaboration of IL-18 via a beta2-AR and NF-kappaB-dependent mechanism. Similar events may occur in heart failure, a disease state characterized by sustained beta-AR activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178407     DOI: 10.1016/j.bbrc.2004.04.185

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.

Authors:  Balachandar Venkatesan; Anthony J Valente; Sumanth D Prabhu; Prakashsrinivasan Shanmugam; Patrice Delafontaine; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2010-06-09       Impact factor: 5.000

2.  β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Authors:  David R Murray; Srinivas Mummidi; Anthony J Valente; Tadashi Yoshida; Naveen K Somanna; Patrice Delafontaine; Charles A Dinarello; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2011-10-08       Impact factor: 5.000

3.  Beta(2)-Adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP.

Authors:  D L Yamamoto; D S Hutchinson; T Bengtsson
Journal:  Diabetologia       Date:  2006-11-22       Impact factor: 10.122

4.  Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.

Authors:  James T Colston; William H Boylston; Marc D Feldman; Chris P Jenkinson; Sam D de la Rosa; Amanda Barton; Rodolfo J Trevino; Gregory L Freeman; Bysani Chandrasekar
Journal:  Biochem Biophys Res Commun       Date:  2007-01-16       Impact factor: 3.575

Review 5.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

6.  Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity.

Authors:  Andrey J Serra; Marília H H Santos; Danilo S Bocalini; Ednei L Antônio; Rozeli F Levy; Alexandra A Santos; Maria L Higuchi; José A Silva; Flávio C Magalhães; Valério G Baraúna; José E Krieger; Paulo J F Tucci
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

7.  Okadaic acid induces matrix metalloproteinase-9 expression in fibroblasts: crosstalk between protein phosphatase inhibition and β-adrenoceptor signalling.

Authors:  A Rietz; Y Volkov; A Davies; M Hennessy; J P Spiers
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 8.  The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease.

Authors:  Simon W Rabkin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 9.  Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.

Authors:  Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo
Journal:  Mol Med       Date:  2014-06-12       Impact factor: 6.354

10.  FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart.

Authors:  Alina G Sofronescu; Karen A Detillieux; Peter A Cattini
Journal:  Cardiovasc Res       Date:  2010-01-22       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.